drc-conflict

Congo asked for 500,000 doses of Ebola vaccine in August. The world sent 70,000. That is 14 percent of what the response needed, and the gap was not measured in test tubes. It was measured in mothers who will bury children, nurses who will catch the virus from the patients they are holding, and villages that will learn too late that help existed in a warehouse somewhere while they were dying.
Let us be precise about what is happening. The Bundibugyo strain of Ebola is spreading in the Democratic Republic of Congo, and the cases have already crossed its borders into neighbouring countries. There is no licensed vaccine for this strain. The vaccine that does exist at scale, ERVEBO®, was built for a different species of the virus. It is licensed for people aged one and above, and it has been used in DRC before, including during the 2018 to 2020 outbreak in North Kivu that killed more than 2,000 people. Médecins Sans Frontières, which runs some of the most exposed frontline clinics in the country, says the vaccine may still protect people against this strain. Its teams have reported fewer confirmed cases and signs of lower mortality among people who received ERVEBO® before the current outbreak. These are field observations from people who are not politicians and have no reason to inflate them. They are the people who carry the bodies.
So why are the doses not in the arms of the people who need them?
Because access has been wrapped in red tape. Frontline health workers can be vaccinated only through research protocols or compassionate-use mechanisms that are slow, complicated, and built for trial logistics rather than a burning epidemic. Contacts of confirmed cases, the very people the response must reach first, can generally get the vaccine only if they happen to be enrolled in an ongoing clinical trial. Trials with strict criteria will enroll a small fraction of those who could benefit. Everyone else waits. Ebola does not wait. It moves through households, markets, health centres and funerals, and every week of bureaucratic hesitation is a week in which it finds new hosts.
The Ministry of Health in Kinshasa has already widened compassionate use. Good. But that effort needs more doses from existing stockpiles, and those stockpiles are controlled through the World Health Organization's International Coordinating Group on Vaccine Provision. The World Health Organization's Strategic Advisory Group of Experts on Immunization meets on 17 November to decide how far the release can go. Until then, Congolese lives are being held in a queue whose rules were written in Geneva and whose consequences are paid in Ituri, North Kivu and Kasai.
Here is the question nobody in those rooms wants to answer. If 500,000 doses were requested and 70,000 were released, who decided that 430,000 Congolese did not need protection? On what evidence? Under what criteria? And who is accountable when the answer turns out to be a spreadsheet and a shortage?
The sad truth is that eastern Congo has been bleeding for three decades, and that bleeding makes every epidemic deadlier. The eastern provinces where Ebola is now spreading are the same provinces where the Rwandan-backed M23 rebels have seized large territory, including the provincial capitals of Goma and Bukavu. UN Group of Experts reports, most recently S/2026/466 and its predecessor S/2025/446, have documented the Rwandan Defence Force's direct role in this war, including the deployment of Rwandan combat units alongside M23 fighters. When a sovereign state sends its army across an internationally recognised border, occupies territory, and forces health facilities, roads and supply chains into chaos, it is not a neutral bystander to an outbreak. It is a contributor to the conditions in which the outbreak thrives. Health systems cannot track contacts in a war zone. Labs cannot run diagnostics where the power is out and the roads are closed. Doctors cannot work where armed men shoot at ambulances. Kigali sends its soldiers and then sends its diplomats to lecture the world about stability. Congolese families are the ones paying the price.
We have seen what competent response looks like. Rwanda, for all its aggression in our neighbourhood, contained a Marburg outbreak in 2024 with rapid case isolation, disciplined contact tracing and fast public communication. Senegal has shown that strong institutions and transparent public health reporting can save lives during emergencies. Botswana has built decades of credibility by managing its resources through rules rather than favours. The lesson is not that Africa lacks capacity. The lesson is that capacity without accountability, and response without transparent supply rules, produces shortages that kill.
So what must happen, and who must act?
First, the WHO's Strategic Advisory Group must lift research-linked restrictions on ERVEBO® and release the doses the outbreak demands. Ministries of health should not have to beg for a fraction of what they requested. The ICG should publish, in plain language, how it allocated the 70,000 doses, what alternatives were considered, and who signed off. Transparency is not a favour to the public. It is the basic condition of legitimacy in any institution that spends other people's lives.
Second, Africa must stop depending on distant factories to protect its own people. The African Union, through Africa CDC and the African Vaccine Manufacturing Accelerator, must fund regional production capacity with binding offtake agreements so that countries are not left waiting for a company in another hemisphere to decide their priorities. Pooled procurement with published stockpile ledgers would let every African parliament see, in real time, where vaccines sit and who controls them. Markets work best when they are open and contracts are enforceable. Vaccines are no exception.
Third, the UN Security Council must treat the deliberate destabilisation of eastern Congo as a threat to health security, not merely to territorial integrity. Sanctions on the commanders and foreign backers sustaining this war should be enforced, and humanitarian corridors must be guaranteed so that vaccines, labs and health workers can reach the communities that need them.
And you, the reader, have a role. Ask your government what it has pledged to the Ebola response, and whether it has demanded that the 430,000 withheld doses be released. Ask your media why the story of a stalled vaccine shipment is buried beneath celebrity news. Ask the regional bodies you pay for what they are doing differently this time.
We are not asking for pity. We are demanding the basic competence and honesty that every Congolese child deserves: a vaccine when the virus arrives, a government that tells the truth about its supplies, and an end to the war that turns every epidemic into a massacre. The Ebola virus does not care about passports or spreadsheets. Only we can make those institutions care.
Based on reporting by RELIEFWEB